Research programme: dual 5-lipoxygenase inhibitor and histamine H1 receptor antagonists - UCB Research
Alternative Names: UBC 34743; UCB 62045; UCB34743Latest Information Update: 17 Jul 2007
At a glance
- Originator UCB Research
- Class
- Mechanism of Action 5-lipoxygenase inhibitors; Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Allergic rhinitis; Asthma
Most Recent Events
- 17 Sep 2002 Preclinical trials in Allergic rhinitis in Belgium (unspecified route)
- 17 Sep 2002 Preclinical trials in Asthma in Belgium (unspecified route)